Halozyme Announces US FDA Approval of Roche's Tece...
Category : Approval/Launch 16 September 2024Halozyme announces US FDA approval of Roche's Tecentriq Hybreza with Enhanze for multiple types...
Halozyme announces US FDA approval of Roche's Tecentriq Hybreza with Enhanze for multiple types...
VYNE Therapeutics reports positive phase 1a SAD data for VYN202, a novel BD2-selective BET inhibitor...
Aura Biosciences announces positive results from phase 2 end of study of bel-sar as a first-line tre...
Pfizer’s Braftovi+Mektovi shows long-term clinically meaningful response in patients with BRAF...
Overview Envision Pharma Group, a leading global technology solutions partner, has launched its n...